Keyphrases
Cost-effectiveness
68%
United States
60%
Multiphase Optimization Strategy
41%
Breast Cancer
41%
Computed Tomographic Colonography
39%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
35%
Chemotherapy
33%
Cost-effectiveness Analysis
32%
Quality-adjusted Life Years
32%
Lobectomy
31%
Confidence Interval
28%
Odds Ratio
27%
Breast Cancer Diagnosis
27%
Hematopoietic Cell Transplantation
26%
Acute Myeloid Leukemia
25%
Locally Advanced Breast Cancer
24%
Healthcare Utilization
24%
Healthcare
23%
Drug Costs
22%
Clinical Trials
21%
Economic Evaluation
20%
Surveillance Imaging
20%
Hospitalist
20%
Osteoporosis
20%
Meta-analysis
20%
Locoregional Recurrence
20%
Pembrolizumab
20%
Microsimulation
20%
Liver Transplant Recipients
20%
Extracolonic Findings
20%
Employer-sponsored Health Insurance
20%
Length of Stay
20%
Intervention Optimization
19%
Randomized Controlled Trial
19%
Health Insurance
19%
COVID-19
19%
Magnetic Resonance Imaging
19%
Breast Reconstruction
17%
Health Care Costs
17%
Comorbidity
17%
Liver Transplantation
17%
Health Outcomes Research
16%
Distant Recurrence
16%
Incremental Cost-effectiveness Ratio
15%
Hip Fracture
15%
Surgeons
15%
Medical Care
15%
Employment Insurance
15%
Health Status
15%
Families with children
15%
Medicine and Dentistry
Health Care Cost
100%
Breast Cancer
68%
Cost-Effectiveness Analysis
50%
Cell Transplantation
50%
Magnetic Resonance Imaging
46%
Virtual Colonoscopy
41%
Medicare
31%
Systematic Review
31%
Recurrent Disease
31%
Lobectomy
31%
Prevalence
27%
Malignant Neoplasm
26%
Acute Myeloid Leukemia
25%
Health Care
24%
Cancer Diagnosis
22%
Outpatient
22%
Computer Assisted Tomography
21%
Checklist
20%
Meta-Analysis
20%
Emergency Department
16%
Colonoscopy
16%
Randomized Controlled Trial
15%
Emergency Care
15%
Maximum Likelihood Method
15%
Surgeon
15%
Subacute Care
13%
Diseases
13%
Health Outcomes
13%
Quality Adjusted Life Year
12%
Diagnosis
12%
Recurrence Risk
12%
Cancer Therapy
11%
Artificial Respiration
11%
Clinical Trial
11%
Base
11%
Thyroidectomy
10%
Logistic Regression Analysis
10%
Receptor
10%
Rating Scale
10%
Thyroid Nodule
10%
Papillary Thyroid Cancer
10%
Statin
10%
Genetic Screening
10%
Thyrotropin
10%
Thyroxine
10%
Mass Screening
10%
Placebo
10%
Behavioral Change
10%
Ischemic Heart Disease
10%